Seattle, WA | May 7, 2013
Seattle, WA, May 7, 2013: IDRI (Infectious Disease Research Institute) has officially moved from its long-time residence in Seattle’s First Hill neighborhood to its new home at 1616 Eastlake Avenue East, where it will occupy approximately 55,000 square feet, principally on the fourth floor of the building. IDRI is leasing the space from real estate partner Alexandria Real Estate Equities, Inc., and worked with Aedas, an international architecture and design firm, as well as BNBuilders, a West Coast construction company, to update the space to meet its current needs and allow for future growth. IDRI’s move to the South Lake Union neighborhood puts it in midst of Seattle’s growing global health/life sciences hub, where it has many partners and collaborators.
The majority of the space contains general laboratories, as well as specialized facilities including a GMP manufacturing suite, rooms for drug discovery robotics and IDRI’s new Human Immune Monitoring Center. By re-utilizing materials and office space configurations from the previous tenant, IDRI saved more than $1 million in its build-out, which was put toward developing state-of-the art labs. The space allows IDRI’s staff and scientists, who were previously spread across three floors of a two-building complex, to consolidate almost all activities on one floor.
“At IDRI, our motto is ‘science first’,” said Stewart Parker, IDRI CEO. “Our main goal is to enable our scientists to do their work in the most collaborative environment to fulfill our mission of researching and developing new products for global infectious diseases.” Parker added that transparency is a theme that carries through in the lab, which has an open floor plan, and the office space, which is filled with large windows and relights.
The space was also designed with the public in mind, featuring interactive tour stops throughout the lab space that use technology to underscore IDRI’s work in developing vaccines, drugs and diagnostics, as well as large built-in windows to showcase IDRI’s specialized facilities, including manufacturing. There is also a flexible meeting space, where IDRI can host educational events for up to 100 people.
As a nonprofit global health organization, IDRI (Infectious Disease Research Institute) takes a comprehensive approach to combat infectious diseases, combining the high-quality science of a research organization with the product development capabilities of a biotech company to create new diagnostics, drugs and vaccines. IDRI combines passion for improving human health with the understanding that it is not just what our scientists know about disease, but what we do to change its course that will have the greatest impact. Founded in 1993, IDRI has 125 employees headquartered in Seattle with more than 50 partners/collaborators around the world. For more information, visit www.idri.org.
IDRI: Lee Schoentrup | 206.518.6290 | email@example.com